Photodistributed lichenoid drug eruption secondary to solifenacin.
Shalders
K
K
Gach
J E
JE
D000897:Anti-Ulcer Agents / Q000009:adverse effects; D000924:Anticholesteremic Agents / Q000009:adverse effects; D003875:Drug Eruptions / Q000188:drug therapy / Q000473:pathology*; D004347:Drug Interactions; D006801:Humans; D017512:Lichenoid Eruptions / Q000139:chemically induced / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D018727:Muscarinic Antagonists / Q000009:adverse effects*; D017202:Myocardial Ischemia / Q000188:drug therapy; D011803:Quinine / Q000009:adverse effects; D011812:Quinuclidines / Q000009:adverse effects*; D000069464:Solifenacin Succinate; D013473:Sunscreening Agents / Q000627:therapeutic use; D044005:Tetrahydroisoquinolines / Q000009:adverse effects*; D016896:Treatment Outcome; D053201:Urinary Bladder, Overactive / Q000188:drug therapy
D000897:Anti-Ulcer Agents; D000924:Anticholesteremic Agents; D018727:Muscarinic Antagonists; D011812:Quinuclidines; D013473:Sunscreening Agents; D044005:Tetrahydroisoquinolines; D011803:Quinine; D000069464:Solifenacin Succinate